نتایج جستجو برای: remission maintenance therapy

تعداد نتایج: 804901  

2016
Zong Mei Zhang Wei Li Xue Liang Jiang

BACKGROUND/AIMS To evaluate the efficacy and safety of adalimumab (ADA) in moderately to severely active ulcerative colitis (UC) patients who are unresponsive to traditional therapy. METHODS Electronic databases, including the PubMed, Embase, and Cochrane databases, were searched to April 20, 2014. UC-related randomized controlled trials (RCTs) that compared ADA with placebo were eligible. Re...

ژورنال: اعتیاد پژوهی 2013
اکبری, سعید , حدادی, روح ‏الله , سلطانی‏نژاد, نفیسه , فتحی‏ناز, حمیدرضا, کریمی, مهدی ,

Aim: The aim of the study was to compare the effectiveness of Risperidone and Fluoxetine in combination with impulse control group therapy on improving of impulsivity, and relapse in heroin crack addicts under methadone maintenance therapy. Method: In a semi-experimental study, 39 heroin crack addicts who were under Methadone maintenance treatment selected of addiction withdrawal centers in Teh...

Journal: :Gastroenterology & hepatology 2013
Kian Keyashian

KK Thiopurines are slow-acting drugs, taking up to 6 months to reach a therapeutic effect. They can be used by themselves as monotherapy or in combination with other therapies. If they are tolerated as monotherapy and if remission of inflammatory bowel disease (IBD) is achieved, then they are good choices for long-term maintenance therapy. Studies have shown that discontinuing therapy results i...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006
Cecile Grootscholten Jo H M Berden

The search for an optimal therapy for proliferative lupus nephritis (LN) is still ongoing [1,2]. Maintenance treatment most often consists of low-dose prednisone, generally combined with either azathioprine, hydroxychloroquine or mycophenolate mofetil. Since the prognosis of proliferative LN has improved considerably and the morbidity of therapy is substantial, the aim of treatment has changed ...

Journal: :Blood 2004
Miguel A Sanz Edo Vellenga Chelo Rayón Joaquín Díaz-Mediavilla Concha Rivas Elena Amutio Jesús Arias Guillermo Debén Andrés Novo Juan Bergua Javier de la Serna Javier Bueno Silvia Negri José M Beltrán de Heredia Guillermo Martín

Therapeutic results in elderly patients with acute promyelocytic leukemia (APL) have been generally reported as less effective than for younger patients. Patients 60 years or older with APL who were enrolled in 2 successive multicenter PETHEMA studies received induction therapy with all-trans retinoic acid (ATRA) and idarubicin, consolidation with 3 anthracycline monochemotherapy courses with o...

2009
Jean-Luc Harousseau

The treatment of multiple myeloma (MM) has changed dramatically in the past twenty years with the introduction of high-dose therapy plus autologous stem-cell transplantation (ASCT) in younger patients and, more recently, of three novel agents (thalidomide, bortezomib, and lenalidomide). When conventional chemotherapy was the only available possibility, complete responses (CR) were very rare and...

Journal: :Journal of managed care pharmacy : JMCP 2007
William N Tindall John M Boltri Sheila M Wilhelm

BACKGROUND Ulcerative colitis (UC) is a chronic relapsing disease necessitating lifelong treatment. Most patients present with mild-to-moderate disease characterized by alternating periods of remission and clinical relapse. Continued disease progression and relapse of UC over time are associated with an increased risk of colorectal cancer (CRC). OBJECTIVE To discuss the latest treatment optio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید